Pancreatic Cancer Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who carry known gene changes (mutations) that raise their risk of developing cancer
• People with a personal or family history that suggests a higher-than-average cancer risk, even if genetic testing came back negative or has not been done
• People who have been clinically diagnosed with a condition that increases cancer risk, such as neurofibromatosis, Fanconi Anemia, or Ataxia-Telangiectasia
• People identified by a cancer risk prediction tool as being at elevated risk
• People at higher cancer risk due to factors such as past exposures, obesity, gender, race, ethnicity, or HPV exposure
• Childhood or adult cancer survivors whose treatments may have increased their future cancer risk
• People with documented high-level exposure to substances officially classified as cancer-causing (Group 1 carcinogens)
• People at risk for lung cancer, for example those over age 50 with a significant smoking history or a close family member with lung cancer or COPD
• People with certain liver conditions, such as alcoholic liver disease, fatty liver disease, or cirrhosis
• People with certain pre-cancerous breast changes, such as ductal or lobular carcinoma in situ or atypical cell growth
• People with certain pre-cancerous digestive conditions, such as Barrett's esophagus, pancreatic precursor lesions, or colon polyps/dysplasia
• People with certain pre-cancerous conditions of the urinary or reproductive system (confirm with trial site)
• People with certain pre-cancerous lung findings, such as abnormal cell growth or lung nodules found on a screening scan that need further monitoring
• People with pre-cancerous conditions of the mouth, head, or neck area
• People with certain pre-cancerous skin conditions, such as specific melanocytic lesions or squamous dysplasia
• People with certain early blood or bone marrow conditions that may develop into blood cancers, such as CHIP (clonal hematopoiesis of indeterminate potential), MGUS (abnormal proteins in the blood), smoldering myeloma, or low-grade lymphomas
• People with certain pre-cancerous gynecological conditions, such as early changes in the fallopian tubes, uterus, cervix, or vulva
• Children with certain tissue findings sometimes linked to future cancer risk, such as kidney rests, certain bone lesions, or Spitz nevus
• Family members of people at cancer risk, or healthy individuals

Who may not be able to join:

• There are currently no exclusion criteria for this study — the trial states that almost anyone may be eligible to participate
• People with a previous cancer diagnosis are still allowed to join
• People with a history of non-spreading (non-metastatic) localized cancers, such as skin cancer or localized prostate cancer, are still allowed to join
• People already enrolled in other clinical trials or receiving treatment for a pre-cancerous condition are still allowed to join

⚠️ Important: Always verify eligibility with the trial site directly before applying.